Orthosensor
Dania Beach, US · Delaware corporation
Founders & leadership
RB
ROMAN BENSENExecutive
MS
Marc SteinExecutive
ID
IVAN DELEVICExecutive
JP
JAY PIERCEExecutive
RB
Roman BensonExecutive
MR
MARTIN ROCHE, MDNamed on SEC filing
Board
DM
David MatlinBoard director
CO
Charles O'MearaBoard director
SB
STEVEN B. EPSTEINBoard director
MA
MANUEL AGUEROBoard director
FD
Floyd D. Loop, M.D.Board director
MS
Michael StanskyBoard director
Reported raises · per SEC filings
Form D private placements$80.7M disclosed across 13 rounds · 2013–2020
▶$1.5MraisedNov 2020 · 1 investors · Other Health CareRule 506(b)
▶$1.5MraisedNov 2020 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Martin Roche, MDExecutive Officer, Director
- Manuel AgueroDirector
- Michael StanskyDirector
- David MatlinDirector
- Mark BaumgartnerDirector
- Roman BensenExecutive Officer
- Chris DeweyDirector
- Jonathan TrousdaleExecutive Officer
- Chang Kyu KimDirector
- John LeoExecutive Officer
- Steve SegerExecutive Officer
- John MastrototaroExecutive Officer
- Ivan DelevicExecutive Officer, Director
- Offering amount
- $16M
- Amount sold
- $1.5M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedOct 2020 · 5 investors · Other Health CareRule 506(b)
▶$1.3MraisedOct 2020 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Manuel AgueroDirector
- Chris DeweyDirector
- John MastrototaroExecutive Officer
- Steve SegerExecutive Officer
- John LeoExecutive Officer
- Chang Kyu KimDirector
- Jonathan TrousdaleExecutive Officer
- Ivan DelevicExecutive Officer, Director
- Roman BensenExecutive Officer
- Mark BaumgartnerDirector
- David MatlinDirector
- Martin Roche, MDExecutive Officer, Director
- Michael StanskyDirector
- Offering amount
- $2.5M
- Amount sold
- $1.3M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.5MraisedOct 2020 · 1 investors · Other Health CareRule 506(b)
▶$6.5MraisedOct 2020 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John MastrototaroExecutive Officer
- Chris DeweyDirector
- John LeoExecutive Officer
- Chang Kyu KimDirector
- Jonathan TrousdaleExecutive Officer
- Ivan DelevicExecutive Officer, Director
- Steve SegerExecutive Officer
- Martin Roche, MDExecutive Officer, Director
- Manuel AgueroDirector
- Michael StanskyDirector
- David MatlinDirector
- Mark BaumgartnerDirector
- Roman BensenExecutive Officer
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MraisedMay 2020 · 8 investors · Other Health CareRule 506(b)
▶$6.3MraisedMay 2020 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan TrousdaleExecutive Officer
- Roman BensenExecutive Officer
- Manuel AgueroDirector
- Ivan DelevicExecutive Officer, Director
- Chris DeweyDirector
- Martin Roche, MDExecutive Officer, Director
- Chang Kyu KimDirector
- John LeoExecutive Officer
- Mark BaumgartnerDirector
- Michael StanskyDirector
- John MastrototaroExecutive Officer
- David MatlinDirector
- Steve SegerExecutive Officer
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.8MraisedJul 2019 · 19 investors · Other Health CareRule 506(b)
▶$9.8MraisedJul 2019 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Manuel AgueroDirector
- Martin Roche, MDExecutive Officer, Director
- Mark BaumgartnerDirector
- David MatlinDirector
- John MastrototaroExecutive Officer
- Steven SegerExecutive Officer
- John LeoExecutive Officer
- Chang Kyu KimDirector
- Jonathan TrousdaleExecutive Officer
- Michael StanskyDirector
- Roman BensenExecutive Officer
- Ivan DelevicExecutive Officer, Director
- Offering amount
- $9.8M
- Amount sold
- $9.8M
- Sales commissions
- $200K
- Placement agents
- Ceros Financial Services, Inc.
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedNov 2018 · 9 investors · Other Health CareRule 506(b)
▶$6MraisedNov 2018 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David MatlinDirector
- Martin Roche, MDExecutive Officer, Director
- Lalitendu PandaExecutive Officer
- Ivan DelevicExecutive Officer, Director
- Mark BaumgartnerDirector
- Michael StanskyDirector
- John LeoExecutive Officer
- Steven B. EpsteinDirector
- Manuel AgueroDirector
- Chang Kyu KimDirector
- Roman BensenExecutive Officer
- Jonathan TrousdaleExecutive Officer
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.2MraisedJul 2018 · 9 investors · Other Health CareRule 506(b)
▶$5.2MraisedJul 2018 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Martin Roche, MDExecutive Officer, Director
- Ivan DelevicExecutive Officer, Director
- Roman BensenExecutive Officer
- Stephen Charles O'MearaDirector
- John LeoExecutive Officer
- David MatlinDirector
- Jonathan TrousdaleExecutive Officer
- Michael StanskyDirector
- Manuel AgueroDirector
- Chang Kyu KimDirector
- Lalitendu PandaExecutive Officer
- Steven B. EpsteinDirector
- Offering amount
- $5.2M
- Amount sold
- $5.2M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.8MraisedApr 2018 · 4 investors · Other Health CareRule 506(b)
▶$2.8MraisedApr 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Manuel AgueroDirector
- Chang Kyu KimDirector
- David MatlinDirector
- John LeoExecutive Officer
- Michael StanskyDirector
- Ivan DelevicExecutive Officer, Director
- Roman BensenExecutive Officer
- Martin Roche, MDExecutive Officer, Director
- Lalitendu PandaExecutive Officer
- Stephen Charles O'MearaDirector
- Steven B. EpsteinDirector
- Jonathan TrousdaleExecutive Officer
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Orthosensor raised?
- Orthosensor has disclosed $80.7M raised across 13 rounds.
- Where is Orthosensor headquartered?
- Orthosensor is headquartered in Dania Beach, US.